Scholarlink

Background <p>People with HIV (PWH) are more likely to smoke, have comorbidities, and be less likely to quit than the general population. This study aimed to describe the prescription of smoking cessation medications and quit smoking attempts, and to assess the effect of prevalent and incident comorbidity diagnoses on these two outcomes.</p> Methods <p>We analyzed the 2007–2022 HIV Outpatient Study (HOPS) medical records and self-reported risk behavior survey data. We included adult PWH with evidence of current cigarette use at enrollment (baseline) or incident cigarette use. Comorbidities were identified based on laboratory results, clinical diagnoses, and treatments. We assessed associations of time-updated (baseline and incident) comorbidity diagnosis with prescription of smoking cessation medications and first attempt to quit using Cox proportional hazards analyses.</p> Results <p>Among 1068 eligible participants followed over a median time of 3.1&#xa0;years (interquartile range 1.2–6.8&#xa0;years), 304 (29%) were prescribed smoking cessation medications. Multivariable factors positively associated with prescribed smoking cessation medications included year of first HOPS visit (adjusted hazard ratio (aHR) 1.09), having diagnoses of depression (aHR 1.39), or chronic obstructive pulmonary disease/emphysema (aHR 1.89). Among 464 people who smoked at baseline and had at least one ACASI survey, during a median follow-up time of 2.3&#xa0;years (interquartile range 0.8–5.2&#xa0;years), 163 (35%) attempted to quit smoking. Multivariable factors positively associated with first attempt to quit included year of first HOPS visit (aHR 1.24), having a diagnosis of depression (aHR 1.30) or bipolar disorder (aHR 1.62), and being prescribed smoking cessation medications (range aHR 2.62–aHR 5.97, depending on the medication), whereas having a diagnosis of psychosis (aHR 0.29), hypertension (aHR 0.41), or obesity (aHR 0.49) was inversely associated.</p> Conclusion <p>In the HOPS, about one-third of smokers were prescribed smoking cessation medications, and of those who completed the risk behavior survey, one-third attempted to quit. Among incident comorbidities examined, time-updated depression was both positively associated with being prescribed smoking cessation medications and attempting to quit smoking. Our results highlight the need for better integration of smoking cessation and prevention programs into PWH care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of Prevalent and Incident Comorbidity Diagnoses on Quit Attempts and Prescription of Smoking Cessation Medications, HIV Outpatient Study, 2007–2022

  • 期刊论文

  • 发表日期：

    2025年10月29日

查看全文
  • Li Jun,
  • Carl Armon,
  • Alexander Ewing,
  • Jonathan Mahnken,
  • Ellen Tedaldi,
  • Frank Palella,
  • Richard M. Novak,
  • Cynthia Firnhaber,
  • Stockton Mayer,
  • Andrea Wendrow,
  • Gina Simoncini,
  • Linda Battalora,
  • Kate Buchacz

摘要

Background

People with HIV (PWH) are more likely to smoke, have comorbidities, and be less likely to quit than the general population. This study aimed to describe the prescription of smoking cessation medications and quit smoking attempts, and to assess the effect of prevalent and incident comorbidity diagnoses on these two outcomes.

Methods

We analyzed the 2007–2022 HIV Outpatient Study (HOPS) medical records and self-reported risk behavior survey data. We included adult PWH with evidence of current cigarette use at enrollment (baseline) or incident cigarette use. Comorbidities were identified based on laboratory results, clinical diagnoses, and treatments. We assessed associations of time-updated (baseline and incident) comorbidity diagnosis with prescription of smoking cessation medications and first attempt to quit using Cox proportional hazards analyses.

Results

Among 1068 eligible participants followed over a median time of 3.1 years (interquartile range 1.2–6.8 years), 304 (29%) were prescribed smoking cessation medications. Multivariable factors positively associated with prescribed smoking cessation medications included year of first HOPS visit (adjusted hazard ratio (aHR) 1.09), having diagnoses of depression (aHR 1.39), or chronic obstructive pulmonary disease/emphysema (aHR 1.89). Among 464 people who smoked at baseline and had at least one ACASI survey, during a median follow-up time of 2.3 years (interquartile range 0.8–5.2 years), 163 (35%) attempted to quit smoking. Multivariable factors positively associated with first attempt to quit included year of first HOPS visit (aHR 1.24), having a diagnosis of depression (aHR 1.30) or bipolar disorder (aHR 1.62), and being prescribed smoking cessation medications (range aHR 2.62–aHR 5.97, depending on the medication), whereas having a diagnosis of psychosis (aHR 0.29), hypertension (aHR 0.41), or obesity (aHR 0.49) was inversely associated.

Conclusion

In the HOPS, about one-third of smokers were prescribed smoking cessation medications, and of those who completed the risk behavior survey, one-third attempted to quit. Among incident comorbidities examined, time-updated depression was both positively associated with being prescribed smoking cessation medications and attempting to quit smoking. Our results highlight the need for better integration of smoking cessation and prevention programs into PWH care.